Sudeep Pharma Quarterly Results for Trading Insights
In Mar 2026, Sudeep Pharma (SUDEEPPHRM) reported revenue ₹189 Cr and net profit ₹49 Cr — revenue +17.4% YoY. For annual financials, live price and key ratios, visit SUDEEPPHRM share price.
SUDEEPPHRM Quarterly Results — Revenue, Profit & EPS Highlights
Sudeep Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore SUDEEPPHRM share price history to track price trends across different timeframes.
- Revenue of ₹189 Cr in Mar 2026 (+15.2% vs Jun 2026, +17.4% vs Mar 2025)
- Net Profit of ₹49 Cr in Mar 2026 (+19.5% vs Jun 2026, +11.4% vs Mar 2025)
- EBITDA of ₹69 Cr in Mar 2026 (+15.0% vs Jun 2026)
- Operating Margin of 34.0% in Mar 2026 (-1.0pp vs Jun 2026)
- Earnings Per Share of ₹4.38 in Mar 2026 (+22.0% vs Jun 2026)
Sudeep Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SUDEEPPHRM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 189 | 164 | 173 | 161 | 130 | 15.2% | 17.4% |
| Net Profit (₹ Cr) | 49 | 41 | 47 | 44 | 31 | - | - |
| EBITDA (₹ Cr) | 69 | 60 | 66 | 63 | 49 | - | - |
| EPS (₹) | 4.38 | 3.59 | 4.20 | 4.07 | 2.84 | - | - |
| Operating Margin (%) | 34.0% | 35.0% | 34.0% | 37.0% | 35.0% | - | - |
SUDEEPPHRM Share Price Trend — 1-Year Movement Across Quarterly Results
Sudeep Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Browse SUDEEPPHRM income statement for revenue, profit, balance sheet and cash flow data.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SUDEEPPHRM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Sudeep Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹463,071.60 Cr | 1875.1 | 15,018 | 2,710 | -5.6% | - | 18.0% | 165.9 |
|
Divis Laboratories
Mar 2026 |
₹225,157.18 Cr | 8588.0 | 2,986 | 751 | -5.0% | - | 25.2% | 303.4 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4971.0 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 431.9 |
|
Cipla
Mar 2026 |
₹117,137.57 Cr | 1431.1 | 6,612 | 543 | -9.3% | - | 8.2% | 208.3 |
|
Zydus Life Science
Mar 2026 |
₹113,855.38 Cr | 1115.6 | 7,569 | 1,341 | -4.3% | - | 17.7% | 88.2 |
All amounts in ₹ Crores